Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aldeyra, Apros, Ascendis, Beigene, Biomarin, Canbridge, Moleculin, Nanomab, Peptilogics, Precision, Reneo, Sellas.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Agex, Ascletis, Asia Green, Atomwise, Berg, Biontech, Biopharma-Middle East and Africa, Caladrius, Chromadex, Cleave, Datavant, Eveliqure, Galmed, GC Pharma, Gigagen, Global Blood Therapeutics Inc., Ibio, Inveniai, Jazz, Johnson & Johnson, Lexicon, Lineage, Merck, Modulus, Monopar, Nkmax, Noden, Ocugen, Otsuka, Pathway, PDL, Pfizer, PNW, Presage, Prism, Redx, SXT, Takeda, Tersera, Tscan, Valneva, Versatope.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: AGTC, Alligator, Ampio, Amryt, Astrazeneca, Aztherapies, Brain Neurotherapy, Cellectar, Clearside, Enterome, Flexion, Intensity, Intra-Cellular, Leukemia & Lymphoma Society, Lipac, Merck, Myokardia, Neurosense, Octapharma, Regenxbio, Roche, Scholar Rock, Sinovac, Trillium, Viking.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Acutus, Alkahest, Arches Research, Assure Holdings, Avacta, Cambus Medical, Co-Diagnostics, Confirm Biosciences, Cytosorbents, Diagnos, Diasorin, Fluidigm, Freudenberg Medical, Grifols, Inovio, Irhythm, Labcorp, Memed, Merit Medical, Neuronostics, Polarity TE, Qiagen, Roche Canada, Seegene, Thermo Fisher Scientific.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alkahest, Anges, Anheart, Aptorum, Astrazeneca, Auris, Aveo, Avidity, Biodesix, Biomica, Biontech, Briacell, Brickell, Canbridge, Catalent, Cheplapharm, CN, Cymerus, Daiichi Sankyo, Destiny, Exelixis, Exmceuticals, Glaxosmithkline, Grifols, Humanigen, Icanomab, Innovation, Inovio, Intravacc, Johnson & Johnson, Kite, Lineage Cell, Mab, Moderna, Mylan, NBE, Novavax, Pharmacyte, Pharmamar, Phoremost, Protalix, Recce, Redhill, Regenerx, Sanofi, Silence, Sporegen, Takeda, Vaxart, Vaxil, Vyne, Xtalpi, Zyversa.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Albireo, Allena, Astrazeneca, Athenex, Bayer, Bellus, Biomarin, BMS, Calliditas, Celularity, Clene, Compugen, Corbus, Cyclo, Goldfinch, HRA Pharma, Insmed, Kamada, Merck, Novartis, Radius, Sanofi, Savara, Silence, Spero, Strongbridge, Synairgen, Transgene, Translate Bio, Valneva, Verona.

The latest global regulatory news, changes and updates affecting biopharma, including: Abbvie, Allergan, Astrazeneca, Calvin Scott, Gedeon Richter, HRA Pharma, Nestle.